How does testosterone cream work for perimenopause?

Testosterone cream is a topical preparation that delivers testosterone through the skin into the bloodstream, where it circulates to receptors throughout the body. In the context of perimenopause and menopause, it is used primarily to address low sexual desire (hypoactive sexual desire disorder), but growing evidence also supports its benefits for energy, mood, cognitive function, and muscle strength in some women.

Testosterone is often thought of exclusively as a male hormone, but women produce testosterone throughout their lives. The primary sources are the ovaries and the adrenal glands, with a smaller contribution from peripheral conversion of other steroid hormones. Women's total testosterone levels are much lower than men's, but testosterone plays important physiological roles in female health, including maintaining sexual drive, bone density, muscle function, and cognitive alertness. Women's testosterone levels decline gradually with age, beginning in the mid-30s, with a further decline around perimenopause and menopause as ovarian function decreases. The ratio of testosterone to estrogen also shifts during perimenopause, and in some women increases in sex hormone-binding globulin (SHBG) further reduce bioavailable (free) testosterone even when total levels appear normal.

The primary mechanism by which testosterone improves sexual desire in women involves androgen receptors in the brain's limbic system, particularly in regions governing sexual motivation, arousal, and reward processing. Testosterone binding to these receptors facilitates the brain's responsiveness to sexual stimuli, increasing spontaneous and responsive sexual desire. Testosterone also acts locally in genital tissue, where it enhances blood flow, sensitivity of the clitoral and vulvar tissue, and contributes to lubrication response during arousal. When testosterone levels fall, both the central (brain) and peripheral (genital) components of sexual response can diminish.

The clinical evidence for testosterone in women's sexual health is substantial and increasingly well-established. A landmark 2019 systematic review and meta-analysis published in The Lancet Diabetes and Endocrinology pooled data from 36 randomized controlled trials involving over 8,000 women and found that testosterone therapy significantly improved sexual desire, arousal, frequency of satisfying sexual activity, and pleasure compared to placebo or comparator treatments. Effect sizes were clinically meaningful and consistent across multiple formulations and populations. The International Society for the Study of Women's Sexual Health (ISSWSH) and the Menopause Society both include testosterone as an evidence-based treatment for hypoactive sexual desire disorder (HSDD) in women.

In the United States, no FDA-approved testosterone formulation exists specifically for women's use. Testosterone cream is therefore obtained through compounding pharmacies, where it is typically formulated as a 1 to 2 percent cream. In Australia, AndroFeme 1% cream is the first registered female testosterone product in any country and is used as a reference preparation. In the UK, a licensed testosterone gel intended for male use (Testogel) is commonly used off-label for women at much lower doses. The absence of FDA-approved female formulations in the US creates challenges for standardized dosing, and quality control varies between compounding pharmacies.

Dosing is critical. The goal is to restore testosterone levels to the upper range of the premenopausal female reference range, not to achieve male-range levels. Excessive dosing produces androgenic side effects including acne, oily skin, and increased facial or body hair growth. Regular monitoring of testosterone blood levels ensures that dosing remains within the appropriate female physiological range. Blood tests should check total testosterone and free testosterone (the bioavailable fraction), ideally at a consistent time relative to application.

Cream is typically applied to thin-skinned areas such as the inner thigh or lower abdomen in a small, measured amount. Absorption varies by site and individual factors. Consistent application to the same general area helps standardize absorption over time.

Tracking your symptoms over time, using a tool like PeriPlan, can help you monitor changes in libido, energy, and mood after starting testosterone therapy and provide useful data for your provider at dose review appointments.

When to talk to your doctor: Discuss testosterone cream with a provider experienced in managing women's hormonal health rather than self-medicating with compounded preparations without monitoring. Mention any history of hormone-sensitive cancers, particularly breast cancer, as the safety of testosterone in these women requires individualized assessment with input from oncology. Request baseline and follow-up testosterone levels and discuss what parameters indicate the dose is within the appropriate female range.

This content is for informational purposes only and does not replace medical advice. Always consult your healthcare provider about your specific situation.